Literature DB >> 13009185

The chemotherapy of malaria and trypanosomiasis.

L G GOODWIN.   

Abstract

Entities:  

Keywords:  CATTLE/diseases; MALARIA/therapy; TRYPANOSOMIASIS; TRYPANOSOMIASIS/therapy

Mesh:

Year:  1953        PMID: 13009185      PMCID: PMC2015782          DOI: 10.1136/bmj.1.4805.311

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


× No keyword cloud information.
  9 in total

1.  The treatment of malignant tertian malaria.

Authors:  G COVELL
Journal:  Br Med J       Date:  1949-10-08

2.  A cinnoline compound ("528") for the treatment of Trypanosoma congolense infections.

Authors:  E M LOURIE; J S MORLEY; J C E SIMPSON; J M WALKER
Journal:  Br J Pharmacol Chemother       Date:  1951-12

3.  The impact of protozoa on world economic problems.

Authors:  H E SHORTT
Journal:  Br Med J       Date:  1951-11-10

4.  Preliminary field trials on a new schizonticide.

Authors:  H M ARCHIBALD
Journal:  Br Med J       Date:  1951-10-06

5.  A metabolite of paludrine with high antimalarial activity.

Authors:  H C CARRINGTON; A F CROWTHER; D G DAVEY; A A LEVI; F L ROSE
Journal:  Nature       Date:  1951-12-22       Impact factor: 49.962

6.  Effect of changing the quaternizing group on the trypanocidal activity of dimidium bromide.

Authors:  T I WATKINS; G WOOLFE
Journal:  Nature       Date:  1952-03-22       Impact factor: 49.962

7.  2:4-diaminopyrimidines- a new series of antimalarials.

Authors:  E A FALCO; L G GOODWIN; G H HITCHINGS; I M ROLLO; P B RUSSELL
Journal:  Br J Pharmacol Chemother       Date:  1951-06

8.  Studies in human malaria. XXVIII. Observations on the use of chloroguanide against the Chesson strain of Plasmodium vivax.

Authors:  W C COOPER; G R COATNEY; G M JEFFERY; C A IMBODEN
Journal:  J Natl Malar Soc       Date:  1950-12

9.  Primaquine, SN 13272, a new curative agent in vivax malaria; a preliminary report.

Authors:  J H EDGCOMB; J ARNOLD; E H YOUNT; A S ALVING; L EICHELBERGER; G M JEFFERY; D EYLES; M D YOUNG
Journal:  J Natl Malar Soc       Date:  1950-12
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.